Insulin signaling regulation

Insulin signaling regulation refers broadly to how cells control and respond to signals from insulin—a peptide hormone essential for maintaining energy homeostasis. The core event begins when circulating insulin binds its cell-surface tyrosine kinase receptor—the insulin receptor—triggering autophosphorylation and recruitment/phosphorylation of adaptor proteins like IRS1/IRS2. This initiates two major downstream cascades: • The PI3K-Akt-mTOR axis mediates metabolic actions such as increased glucose uptake via GLUT4 translocation in muscle/adipose tissue, glycogen synthesis, lipid synthesis/storage, protein synthesis, inhibition of gluconeogenesis in liver cells, and suppression of apoptosis. • The Ras-MAPK cascade primarily drives mitogenic/growth responses. Dysregulation at any step can lead to impaired cellular responses known as “insulin resistance,” which underlies type 2 diabetes mellitus and contributes significantly to obesity-related cardiovascular disease and some cancers. Therapeutic interventions often aim at restoring proper function or compensating for defects within this network by targeting specific nodes such as the insulin receptor itself or key kinases like PI3K/Akt/mTOR[1][2][4]. Because “insulin signaling regulation” encompasses many molecules rather than one discrete druggable entity—and because each component may have distinct roles—it should not be used as a canonical name for a molecular target without further specification.

Other names

Insulin signal transductionInsulin pathwayInsulin signaling cascade

Not applicable at the process level; mechanisms depend on which node/protein is targeted. For example: • Agonism/activation of insulin receptor by exogenous insulins. • Modulation of PI3K/Akt/mTOR pathways by various agents.